Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
about
Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Co-delivery of paclitaxel and ...... breast cancer and metastasis.
@ast
Co-delivery of paclitaxel and ...... breast cancer and metastasis.
@en
type
label
Co-delivery of paclitaxel and ...... breast cancer and metastasis.
@ast
Co-delivery of paclitaxel and ...... breast cancer and metastasis.
@en
prefLabel
Co-delivery of paclitaxel and ...... breast cancer and metastasis.
@ast
Co-delivery of paclitaxel and ...... breast cancer and metastasis.
@en
P2093
P1476
Co-delivery of paclitaxel and ...... breast cancer and metastasis.
@en
P2093
Chunli Tian
Chunming Tang
Lingjing Xue
Xinyan Chen
Yidi Zhang
P304
P356
10.1016/J.IJPHARM.2017.06.071
P407
P577
2017-06-19T00:00:00Z